ArticleInternational journal of molecular sciences2026
Endocytosis and Endocytic Neurotrophin Signaling in Developing Spiral Ganglion Neurons.
Article in International journal of molecular sciences, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
Abstract
Spiral ganglion neurons (SGNs) relay auditory information from cochlear sensory cells to the central nervous system (CNS). During development, neurotrophins (NTs) secreted by sensory and supporting cells promote SGN dendrite outgrowth. In injury models, exogenous NTs have been used to stimulate SGN regeneration after damage. Following ligand binding, NT-Trk receptor complexes are internalized and may undergo recycling or degradation, or remain intracellular as "signaling endosomes" that can be retrogradely transported to the soma to influence gene expression, survival, and neuritogenesis. Here, we investigated the role of Trk-containing endosomes in SGNs. Neonatal rat SG explants were treated with BDNF and NT-3 in combination with inhibitors targeting distinct steps of endocytosis. Neurite number and length were quantified and compared to untreated controls. Inhibition of actin polymerization (cytochalasin-B) or dynamin (Dynasore) strongly suppressed neurite outgrowth in both NT-treated and untreated explants. Similarly, inhibitors of clathrin-mediated endocytosis, including those acting upstream of dynamin, reduced neuritogenesis under both conditions. In contrast, inhibition of clathrin-independent pathways diminished neurite growth only in the absence of NTs. Blocking retrograde transport of endosomes to the trans-Golgi network (Retro-2) selectively increased neurite length in NT-treated explants, while inhibition of retrograde transport along neurites (Mycalolide B) markedly reduced both neurite number and extension regardless of NT treatment. These findings suggest that basal SGN neuritogenesis relies on both clathrin-dependent and clathrin-independent endocytosis, whereas NT-induced neurite growth is specifically mediated through clathrin- and dynamin-dependent mechanisms. Although some inhibitors also disrupt actin polymerization, the lack of effect from clathrin-independent inhibitors supports clathrin-mediated internalization as the predominant pathway for NT-driven SGN growth.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.